Non-Arteritic Anterior Ischemic Optic Neuropathy Associated With the Use of Phosphodiesterase Type 5 Inhibitors: A Literature Review

Phosphodiesterase type 5 (PDE5) inhibitors are frequently used for erectile dysfunction (ED) as the first line of treatment. This medication was initially developed to treat muscle spasms and pulmonary hypertension. The United States Food and Drug Administration (FDA) approved its usage for treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Hor, Mosab, Baradeiya, Ahmed M, Qasim, Hodan, Nasr, Mohamed, Mohammad, Amad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437418/
https://www.ncbi.nlm.nih.gov/pubmed/36072219
http://dx.doi.org/10.7759/cureus.27642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437418/
https://www.ncbi.nlm.nih.gov/pubmed/36072219
http://dx.doi.org/10.7759/cureus.27642

Ejemplares similares